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Abstract
Objectives: Caspofungin, currently used as salvage therapy for invasive pulmonary aspergillosis (IPA), strangely only causes
morphological changes in fungal growth in vitro but does not inhibit the growth. In vivo it has good efficacy. Therefore the
question arises how this in vivo activity is reached. Caspofungin is known to increase the amount of chitin in the fungal cell
wall. Mammals produce two chitinases, chitotriosidase and AMCase, which can hydrolyse chitin. We hypothesized that the
mammalian chitinases play a role in the in vivo efficacy of caspofungin.
Methods: In order to determine the role of chitotriosidase and AMCase in IPA, both chitinases were measured in rats which
did or did not receive caspofungin treatment. In order to understand the role of each chitinase in the breakdown of the
caspofungin-exposed cells, we also exposed caspofungin treated fungi to recombinant enzymes in vitro.
Results: IPA in immunocompromised rats caused a dramatic increase in chitinase activity. This increase in chitinase activity
was still noted when rats were treated with caspofungin. In vitro, it was demonstrated that the action of both chitinases
were needed to lyse the fungal cell wall upon caspofungin exposure.
Conclusion: Caspofungin seemed to alter the cell wall in such a way that the two chitinases, when combined, could lyse the
fungal cell wall and assisted in clearing the fungal pathogen. We also found that both chitinases combined had a direct
effect on the fungus in vitro.
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Introduction
Aspergillus fumigatus is a ubiquitous saprophytic fungus, producing
conidia that are inhaled daily by humans. Usually inhalation of
these spores causes no problem; however, A. fumigatus can cause a
broad range of diseases in hosts with underlying conditions.
Patients with inflammatory conditions, such as asthma and cystic
fibrosis, can develop allergic bronchopulmonary aspergillosis
(ABPA) [1,2]. Patients with prolonged neutropenia are at risk to
develop invasive pulmonary aspergillosis (IPA) [3]. In neutropenic
patients, IPA may be characterized by necrotizing pneumonia or
hemorrhagic infarctions. Due to the progressive character of IPA,
the morbidity and mortality is high. The response to treatment is
limited, despite the application of several antifungal agents with
different mechanisms of action.
The current first choice antifungal agent for IPA is voricona-
zole, with amphotericin B as the alternative therapy [3].
Caspofungin is available as salvage therapy, in case of refractory
disease or intolerance of voriconazole or amphotericin B by the
patient. Strikingly, in vitro caspofungin has only a mediocre activity
against A. fumigatus. It does not have fungicidal or fungistatic
activity. Only at a very high concentration growth inhibition is
noted. However, in in vivo animal models caspofungin seems to be
very potent. In our transiently neutropenic rat model with
unilateral invasive pulmonary aspergillosis, the human equivalent
dosage of caspofungin results in 100% efficacy [4]. Therefore the
question arises what the reason is for this discrepancy between in
vivo and in vitro results.
One hypothesis would be that the immune system of the host
plays a role. Caspofungin acts by inhibiting b-glucan synthase
thereby decreasing the b-glucan contents of the fungal cell wall.
To restore the stability of the cell wall, the fungus reacts by
increasing its other major cell wall component, chitin, as
demonstrated in vitro [5,6].
Chitin can be cleaved by chitinases, which belong to family 18
of glycosyl hydrolases and are produced in cooperation with the
immune system. Chitinases are classified into endochitinases and
exochitinases. Exochitinases act at the non-reducing ends of chitin
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with the release of successive diacetyl chitobiose units. In contrast,
endochitinases randomly cleave at internal points in the chitin
chain [7,8]. Mammals are known to produce two types of
chitinases: chitotriosidase and acidic mammalian chitinase (AM-
Case) [9]. Chitotriosidase is produced by macrophages and
polymorphonuclear neutrophils [10,11] and can be found in the
lungs of mammals [12,13] as well as in lacrimal glands [14].
AMCase is an exochitinase produced by macrophages and
epithelial cells [15] and is found mainly in the gastro-intestinal
tract of mammals to digest nutritional chitin, though it was also
found in the lung at low concentrations [10]. The exact role of
chitinases remains to be clarified. However, an important role for
chitinases in allergic diseases has been suggested [16,17].
In the past it was already demonstrated by Overdijk et al. that
chitinase activity was increased in plasma isolated from guinea pigs
with a systemic A. fumigatus infection. Furthermore, high chitinase
levels were detected in the spleen, followed by lungs and kidneys
[18,19]. However, these results did not reveal whether the
chitinase activity was due to chitotriosidase or AMCase activity,
or a combination of both since at that time, AMCase had not been
discovered as a chitinase yet [10].
Summarizing the above, we can state that the chitin content in
the A. fumigatus cell wall is increased upon exposure to caspofungin
and mammalian chitinases are induced during invasive aspergil-
losis. We therefore hypothesized that either chitotriosidase,
AMCase or both play a role in the clearing of A. fumigatus from
the lung when treated with caspofungin. In order to test this
hypothesis, we first determined which of these two chitinases was
induced upon A. fumigatus conidia in both immunocompetent rats,
clearing the conidia, and in immunocompromised rats, suffering
from invasive pulmonary aspergillosis. In these experiments we
determined if chitinases could be induced in the first place during
the neutropenic state. Next, we determined if both chitotriosidase
and AMCase were more extensively expressed during caspofungin
treatment. Afterwards we investigated how these two chitinases
and caspofungin interact and what the combined effect is on the A.
fumigatus hyphae in vitro.
Materials and Methods
Experimental animal model
The rat model of invasive pulmonary aspergillosis (IPA) in
immunocompromised rats used, was described previously [20].
Some minor changes have led to the following experimental set
up.
In order to determine if A. fumigatus conidia induce chitinase
activity, immunocompetent female albino RP rats were inoculated
intratracheally with a clinical isolate of Aspergillus fumigatus
originally isolated from a hemato-oncological patient with IPA.
Left-sided pulmonary inoculation was established by intubation of
the left main bronchus, while the rats were under general
anaesthesia. A cannula was passed through the tube and the left
lung was inoculated with 20 ml phosphate buffered saline (pbs)
containing 66104 conidia of A. fumigatus. Rats were sacrificed at
day 1, 3 and 6 after fungal inoculation of the rats to determine the
chitotriosidase and AMCase activity both enzymatically and
immunohistochemically. For this, blood samples were taken by
puncture of the orbital plexus and rats were sacrificed by CO2
exposure. The left lung was removed and either stored at 280uC
until analysis, or fixated in formalin for immunohistochemistry.
Serum was also stored at 280uC until analysis. The groups
consisted of a minimum of 4 rats. Infected organs and blood from
rats found dead were always cultured to exclude bacterial
superinfections. Fungal load was assessed by determination of
serum galactomannan index (GM-index), using the commercially
available Platelia Aspergillus EIA Platelia Aspergillus system of
BioRad (Marnes-la-Coquette, France).
In order to determine if A. fumigatus conidia induce chitinase
activity in neutropenic female albino RP rats developing IPA,
transient neutropenia was induced by intraperitoneally (i.p.)
administered cyclophosphamide (Endoxan, Baxter, Utrecht, The
Netherlands) in doses of 75, 60, 50 and 40 mg/kg bodyweight at 5
and 1 days before fungal inoculation, and at 3 and 7 days after
fungal inoculation, respectively. Whereas the normal leukocyte
counts in our rats is 5.86109/L, the leukocyte counts decreased
following cyclophosphamide treatment and were 6.56107/L on
the day of fungal inoculation and 6.46107/L on day 5 and day 9
after inoculation. After the last dosage of cyclophosphamide,
leukocyte counts rose to 2.66109/L on day 13 and to 6.06109/L
on day 21 after infection. Granulocyte counts decreased from
26108/L before cyclophosphamide was given (normal counts in
our rats) to 26104/L from the day of fungal inoculation to day 9.
After the final dosage of cyclophosphamide, granulocyte counts
increased again to 1.26107/L and 1.26109/L on day 13 and 21
after infection, respectively.
To prevent bacterial superinfections, rats were given ciproflox-
acin (500 mg/L) and colistin (100 mg/L) in their drinking water.
Furthermore, rats were given teicoplanin intramuscularly (i.m.) in
doses of 30 mg/kg on days 5 and 1 pre- inoculation, and 15 mg/
kg on days 1, 3, 6, 8 and 10 post-inoculation. Immunocompetent
rats were injected with saline i.p. instead of cyclophosphamide.
Left-sided pulmonary infection was established, by intubation as
described for the immunocompetent rats. Again, rats were
sacrificed at day 1, 3 and 6 after fungal inoculation of the rats
to determine the chitotriosidase and AMCase activity both
enzymatically as immunohistochemically as described for the
immunocompetent rats.
Since rats were sacrificed at these predetermined time points,
death of rats was no primary endpoint. Rats were monitored
according to a discomfort scale by the researchers several times a
day, during the entire experiment. In order to limit suffering, rats
were euthanized in case of high discomfort, shown by e.g.
increased breathing exercise, increased respiratory rates and
altered behaviour, like decreased movements and unkempt
appearance (dull haircoat). The experimental protocols adhered
to the rules specified in the Dutch Animal Experimentation Act
(1977) and the Guidelines on the Protection of Experimental Animals
published by the Council of the EC (7a). The present protocols
were approved by the Institutional Animal Care and Use
Committee of the Erasmus MC Rotterdam.
Antifungal treatment
Caspofungin (Merck & Company, Rahway, NJ, USA) was
diluted in saline and administered intraperitoneally once daily in a
dose of 4 mg/kg/day. Treatment was started at 24 h (early stage
IPA) or at 72 h (late stage IPA) after fungal inoculation. Treatment
was continued for six days.
Recombinant expression of rat AMCase
Recombinant rat AMCase was generated using the pMIB insect
cell expression system by Invitrogen as previously described for
human chitotriosidase [14]. The primers had SphI (forward
primer) and Xba1 (reverse primer) restriction sites at the 59 ends
that facilitated the in-frame cloning into pMIB/V5-His (Invitro-
gen). The primer sequences were as follows: RnCHIA-F 59-
GCCCGGGCATGCATtacaatctggtatgctacttcac-39 and RnCHIA-
R 59- GCCCGGTCTAGAtggccagttgcagcaattacagctg-39 (restric-
tion sites underlined). The PCR reactions for generation of full
Chitinases in Experimental Pulmonary Aspergillosis
PLOS ONE | www.plosone.org 2 October 2013 | Volume 8 | Issue 10 | e75848
length AMCase for expression cloning were conducted using Pfu
DNA polymerase (Stratagene) following the manufacturer’s
instructions for a 50 ml reaction using cDNA obtained from rat
lung tissue. The final sequence of the recombinant plasmid was
confirmed by DNA sequencing. The activity of the recombinant
rat AMCase produced here and the purchased recombinant
chitotriosidase were determined with the chitinase assays as
described below.
Chitinase assay
Chitinase activity was determined in homogenized lung tissue.
Activity of 4-Methylumbelliferyl N,N9-diacetyl-b-D-chitobioside
(chitobiosidase activity, corresponding with AMCase activity) and
4-Methylumbelliferyl b-D-N,N9,N0-triacetylchitotriose (endochiti-
nase activity, corresponding with CHIT1 activity) were deter-
mined using the commercial fluorimetric Chitinase Assay Kit
(Sigma-Aldrich Chemie GmbH, Steinheim, Germany). Chitinase
activity in each sample was measured in duplicate. Chitinase
activity was expressed in arbitrary units (a.u.) and median chitinase
activity levels were compared for different groups of rats. Chitinase
activity from Trichoderma viride (control enzyme from the Chitinase
Assay Kit described above) was used as a positive control. A
positive and a negative control were used in each run, in order to
validate the experiment.
Chitotriosidase and AMCase activity were measured in
homogenized lungs. It was confirmed that all chitinase activity
was indeed of host origin as follows: A. fumigatus conidia were
cultured for 48 hours at 37uC in Sabouraud’s broth or RPMI,
with and without caspofungin 1 mg/L. The broth was filtered
after 48 h and chitinase activity in the broth was measured in
triplicate. Activity of chitotriosidase and AMCase was measured
with the commercial fluorimetric chitinase assay kit and was found
to be ,5 a.u. in all samples tested. We thus concluded that the
chitinases measured in the lung tissue were indeed of host origin
and not of fungal origin.
Immunohistochemistry of lungs and in vitro cultures
Lungs were fixed in formalin, embedded in paraffin and
processed for immunohistochemical evaluation. First, lungs were
deparaffinised in xylene, then rehydrated in decreasing concen-
trations of ethanol. Endogenous peroxidase was blocked in
methanol with 0.3% H2O2 and non-specific binding sites were
blocked with rabbit or goat serum. Subsequently, coupes were
incubated overnight with rabbit polyclonal antibody directed
against chitotriosidase (H-66, 1:75, Santa Cruz Biotechnology,
Santa Cruz, USA) or with goat polyclonal antibody directed
against AMCase (Y-14, 1:50, both Santa Cruz Biotechnology,
Santa Cruz, USA). As a control we used a goat polyclonal IgG
antibody directed against swine IgM (A100-100A, 1:50, Bethyl
Laboratories, Montgomery, USA). From the VectaStainH Elite
ABC kit (Vector Laboratories Burlingame, CA, USA), anti-rabbit
IgG or anti-goat IgG was used as a secondary antibody and the
coupes were developed using the protocol from the kit. Hema-
toxylin was used as counter staining. In order to ascertain that the
antibodies did not react with chitinases expressed by A. fumigatus
itself, A. fumigatus was grown on the same histological slides and
fixated. These fixated A. fumigatus slides were stained according to
the same protocol used for the histological slides. No staining of
either chitotriosidase or AMCase was observed.
In vitro binding of chitinases to fungal hyphae
Aspergillus fumigatus was cultured for 48 h at 37uC on Sabour-
aud’s agar with or without 1 mg/L caspofungin, on which a cover
slip had been placed. The fungus adhered to the cover slip and
after 48 h the cover slips were removed and processed. Cover slips
were incubated with 0.5 mg/L recombinant chitotriosidase
(purchased from Sigma-Aldrich Chemie GmbH, Steinheim,
Germany) or with 0.5 mg/L recombinant AMCase (recAMCase;
School of Pharmacy, Nottingham, UK), both or with aquadest for
2 hours at 37uC. Afterwards, cover slips were fixed in 70% and
100% ethanol. Non-specific binding sites were blocked with rabbit
or goat serum. Cover slips were further processed identical to the
lung coupes; however no counter staining was used.
Determination of in vitro inhibitory concentrations
Minimal inhibitory concentrations (MICs) were determined for
recAMCase, recChito and chitinase from T. viride (see section
‘‘Chitinase assay’’) according to the microdilution methods
described by the CLSI [21]. Final concentrations of recAMCase
were 0.031–128 mg/L. Final concentrations of recChito were
0.031–16 mg/L. Final concentrations of chitinase from T. viride
were 0.031–16 mg/L. Minimal effective concentration (MEC) was
determined for caspofungin, according to the same guidelines [21].
Final concentrations of caspofungin were 0.063–128 mg/L.
Checkerboard titrations were conducted in triplicate for
caspofungin combined with recAMCase, recChito and chitinase
from T. viride as a positive control and fractional inhibitory
concentration indices (FICIs) were calculated as previously
published [6]. MEC was used for caspofungin and MICs were
used for chitotriosidase and AMCase. Drug interactions were
classified as synergistic (FICI#0.5), indifferent (0.5,FICI,4) or
antagonistic (FICI$4).
Fungal cell wall assessment by fluorescent microscopy
Aspergillus fumigatus was cultured on a cover slip as described
above. Cover slips were incubated with either recombinant
chitotriosidase alone, recombinant AMCase alone, both recombi-
nant chitinases or with aquadest as negative control for 2 hours at
37uC. Cover slips were washed in aquadest and incubated with
25 mM Calcofluor White (Molecular ProbesH, Leiden, The
Netherlands) for 30 minutes at 37uC in the dark. Afterwards,
cover slips were washed in aquadest and placed on a microscopic
slide and assessed by fluorescent microscopy.
Statistics
Differences in chitinase activity levels between groups were
analysed using the Mann-Whitney U-test (GraphPad Prism
Software, San Diego, USA). A p-value of ,0.05 was considered
significant.
Results
Chitinases in immunocompetent rats inoculated with A.
fumigatus
In order to determine if A. fumigatus conidia induce chitinase
activity, immunocompetent rats were inoculated intratracheally
with A. fumigatus conidia. After inhalation of the inoculum, all rats
remained asymptomatic and none of the rats developed invasive
pulmonary aspergillosis (IPA), their serum galactomannan indices
remained ,0.2 and no hyphae were observed in Grocott-stained
lungs on day 1, day 3 and day 6. Compared to the situation before
inoculation, both chitotriosidase and AMCase activity in the lung
increased on day 1 after inoculation, from 25 to 119 arbitrary units
(a.u.)(chitotriosidase; p= 0.011) and from 17 to 60 a.u. (AMCase;
p = 0.006). After the initial increase in chitinase activity on day 1,
enzyme activity of both chitinases remained elevated on day 3 and
day 6 but did not increase further when compared to day 1
(p.0.05; for all chitotriosidase and AMCase activities see Table
Chitinases in Experimental Pulmonary Aspergillosis
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S1). Thus, exposure of the rats to conidia resulted in increased
activity of both chitotriosidase and AMCase for several days.
However, the data obtained with immunohistochemistry suggested
that inoculation with conidia did not result in increased presence
of chitotriosidase and AMCase in the lung.
Chitinases in immunocompromised rats with IPA
To determine if chitinases were also induced during the
neutropenic state, we investigated chitinase activity in immuno-
compromised rats. Neutrophil depletion was induced using
cyclophosphamide as described in the experimental procedures
section and immunocompromised rats were inoculated intratra-
cheally with A. fumigatus conidia. As previously described, all rats
developed IPA and died within ten days, if left untreated [20].
Bacterial superinfections were never found. IPA was confirmed by
galactomannan indices in serum (figure 1A) and histopathology of
the lung (Grocott staining; figure 2D), which showed invasive
fungal disease.
Chitotriosidase and AMCase activity increased during fungal
infection (Figure 1B, C).
Chitotriosidase activity increased from 75 a.u. before inocula-
tion to 105 a.u. on day 1 (p= 0.041), to 281 a.u. on day 3 and to
501 a.u. on day 6 (both p,0.001). AMCase activity increased from
41 a.u. before inoculation to 61 a.u. on day 1 (p = 0.066), 164 a.u.
on day 3 and 491 a.u. on day 6 (both p,0.001; see Figure 1B,C
and Table S1 for all activities). The initial increase in chitinase
activity on day 1 was similar to that in immunocompetent rats.
However, immunocompromised rats developed invasive fungal
disease and the chitinase activities further increased, indicating
that a higher fungal content was related to both a higher
chitotriosidase and AMCase activity in the lung. Both chitotrio-
sidase and AMCase activity were host specific, since no activity
was found when A. fumigatus culture supernatant were measured.
The histology of lungs of immunocompromised rats with IPA
showed disturbed lung morphology. There was an inflammatory
area around fungal foci, where the normal structure of alveoli was
lost (Figure 2D, E, F). After inoculation, AMCase and chitotrio-
sidase were increasingly expressed around the fungal focus
(Figure 2E, F), which was consistent with the increased chitinase
activity levels as described above. The staining of both chitinases
was deemed specific for host chitinases, since no staining was
observed when A. fumigatus was cultured on a slide and stained
afterwards (see above).
Chitinase activity in immunocompromised rats with IPA
treated with caspofungin
In order to determine if chitinase expression and activity
differed in rats treated with caspofungin, another group of
immunocompromised rats was inoculated with A. fumigatus.
Treatment with caspofungin was started at 24 h post fungal
inoculation, representing early stage IPA. Treatment started at this
early time point resulted in survival of 90% of the rats [20].
Chitotriosidase and AMCase activity initially increased after
fungal inoculation, as described above. In infected caspofungin-
treated rats, at day 3 chitotriosidase and AMCase levels were
similar to the levels in infected untreated rats (Figure 1B, C). On
day 6, a trend was observed that chitotriosidase and AMCase
levels were lower in infected caspofungin-treated rats compared to
infected untreated rats (Figure 1B, C), however the differences
were not statistically significant (for all chitinase activities: see
Table S1) The same trend was found for fungal load, in terms of
GM-index (Figure 1A); GM-index was 5.7 for untreated rats and
2.8 for treated rats (p = 0.053). On day 3, GM-index was lower for
untreated rats than for caspofungin-treated rats, in contrast to
chitinase activity. Apparently, chitinase activity is increased before
GM-index rises.
Immunohistochemistry showed a similar pattern of expression
of chitotriosidase and AMCase in infected caspofungin-treated and
infected untreated rats. Expression of both chitinases was highest
Figure 1. Chitinase activity and fungal load in immunocom-
promised rats inoculated with A. fumigatus conidia. Open
squares: uninfected untreated rats; filled circles: infected untreated
rats; grey triangles: infected rats, treated with caspofungin at 24 h post
infection. Data are means of duplicates. Bars represent medians. For
each group n$4. A. Galactomannan (GM)-index, measured by Platelia
assay. According to the manufacturer’s manual, GM-index of ,0,5 is
considered negative; B, chitotriosidase activity, expressed in arbitrary
units (a.u.); C, AMCase activity, expressed in arbitrary units (a.u.).
* p,0.05; significant difference between the indicated groups.
doi:10.1371/journal.pone.0075848.g001
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around the fungal focus. In other relatively healthy parts of the
lung, expression of chitinases was similar to that in uninfected
rats. Figure 2 shows the fungal focus and the location of the
AMCase and chitotriosidase expressing cells. AMCase was
expressed by several cells throughout the lung, though expres-
sion was also highest around the fungal focus (Figure 2E). After
treatment with caspofungin, AMCase was found to bind to the
fungal cell wall (Figure 2H), though not all hyphae were stained.
This was not seen in hyphae of untreated animals. In unaffected
parts of the infected lung, where normal morphology was
maintained, AMCase expression was comparable with that in
uninfected rats (data not shown). Without caspofungin treat-
ment, chitotriosidase was found also mainly around foci of
fungal growth. No distinct cell type expressing chitotriosidase
could be assigned (Figure 2F). After treatment with caspofungin,
chitotriosidase was found to bind the hyphal cell wall and inside
the cell (Figure 2I). Expression of both chitinases was highest in
close proximity to the fungal focus, regardless of treatment.
Apparently, treatment with caspofungin caused such an
alteration in the fungal cell wall that AMCase was able to bind
the fungal hyphae and chitotriosidase was taken up by the
fungus.
In order to investigate late stage IPA, we also determined
chitinase activity levels in a group of rats that received caspofungin
treatment starting at 72 h post fungal inoculation (late stage IPA).
GM-index and immunohistochemistry revealed increased fungal
load compared to rats that were treated with caspofungin starting
at 24 h post inoculation (early stage IPA). For chitinase activity, we
observed levels that were not significantly different between the
two groups (see Table S1).
In vitro binding of recombinant chitinase to hyphae of A.
fumigatus
As described above, we observed binding of AMCase and
hyphal uptake of chitotriosidase in the lung after treatment with
caspofungin. We hypothesized that treatment with caspofungin
was required for binding of both chitinases, since caspofungin
causes increased chitin contents in the fungal cell wall [6] and thus
increases the substrate for chitinases. In order to confirm our
hypothesis, we investigated in vitro binding of recombinant
Figure 2. Grocott staining (A, D, G) and presence of AMCase (B, E, H) and chitotriosidase (C, F, I) in several rats. Panels A, B, and C show
the lung of an uninfected rat. Panels D, E and F show the fungal focus in an infected, untreated rat. Panels G, H and I show the fungal focus in an
infected, caspofungin treated rat. Original magnification6400. All panels represent lungs on day 6 after inoculation. Slides were stained according to
the described protocols. In Grocott staining (A, D, G), fungal hyphae are coloured black. Chitotriosidase- or AMCase-presenting cells are coloured red
(B, C, E, F, H, I). In uninfected rats, normal morphology can be found in the lungs (A, B, C). In infected rats, normal morphology of alveoli is lost (D, E, F).
Grocott staining shows many hyphae (D). An inflammatory response is found around the fungal focus, where chitotriosidase and AMCase are
increasingly present (red zones) compared to an uninfected rat (E, F). After treatment with caspofungin, Grocott staining shows fungal material in all
infected rats (G). AMCase bound fungal hyphae after treatment with caspofungin (H) and thus hyphae became visible. After treatment with
caspofungin, chitotriosidase seemed to also bind the fungal cell wall and locate inside hyphal cells (I).
doi:10.1371/journal.pone.0075848.g002
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AMCase and recombinant chitotriosidase to A. fumigatus hyphae
on slides. A. fumigatus was cultured on cover slips in presence or
absence of caspofungin, which was followed by exposure to
recombinant AMCase or recombinant chitotriosidase or both for
two hours. Binding of the enzyme was detected in the same way as
expression was detected in the lungs taken from rats with IPA.
Additionally, we tested antifungal activity of recombinant AMCase
or recombinant chitotriosidase alone and combined with caspo-
fungin in a checkerboard titration according to the CLSI criteria.
Recombinant AMCase did bind similarly to fungal hyphae both
in unexposed and in caspofungin-exposed fungal cells (Figure 3E,
F), showing that caspofungin exposure was not needed for binding
of AMCase. Susceptibility testing showed a median minimal
inhibitory concentration (MIC) of recombinant AMCase of
.16 mg/L. Combination of recombinant AMCase with caspo-
fungin in a checkerboard titration showed no synergy (median
fractional inhibitory concentration index [2] 2.0). Thus exposure
to caspofungin and recombinant AMCase was not sufficient for
antifungal activity in vitro.
Recombinant chitotriosidase was not taken up by A. fumigatus
hyphae during incubation with this enzyme regardless of
caspofungin exposure (Figure 3A,B), in contrast to what was seen
in infected lungs. Susceptibility testing showed an MIC of
recombinant chitotriosidase of .16 mg/L. Combination of
recombinant chitotriosidase with caspofungin in the checkerboard
titration showed again no synergy (median FICI 2.0). Thus
exposure to caspofungin and recombinant chitotriosidase alone
was also not sufficient for antifungal activity in vitro.
Strikingly the binding pattern of recombinant chitotriosidase in
the infected lungs was different to the pattern found in vitro. In vivo,
both chitinases were present, though only one chitinase was
stained at a time. Hence we additionally investigated the binding
of recombinant chitotriosidase to the fungus in presence of both
recombinant enzymes in vitro. When hyphae were not exposed to
caspofungin, chitotriosidase seemed to locate inside the hyphae
and was also bound to the conidial heads (Figure 3C). When
hyphae were exposed to caspofungin and to both recombinant
chitinases, chitotriosidase also located inside the cell wall and
strikingly, the cell wall seemed to dissolve (Figure 3D). From these
experiments, we observed that recombinant chitotriosidase could
only be taken up by hyphae, provided recombinant AMCase was
present. Furthermore we observed that caspofungin modifies the
fungal cell wall in such a way, that a combination of recombinant
AMCase and recombinant chitotriosidase can lyse the fungal cell
wall. The uptake of chitotriosidase and morphologic disruptions
suggest chitinolytic results and thus clinical significance in the
clearance of fungal material.
We aimed to confirm this important finding in an alternative
experiment. It was not possible to conduct a checkerboard titration
with caspofungin and both recombinant chitinases, due to limited
availability of recombinant enzymes. Other types of viability assays
were unfortunately also not successful. Instead of a viability assay,
we then stained the fungal cell wall with Calcofluor White after
exposure to caspofungin and both recombinant chitinases.
Figure 4A shows unexposed fungal cells and Figure 4B shows
caspofungin-exposed cells, both after incubation with a combina-
tion of recombinant chitotriosidase and recombinant AMCase.
These panels are representative for the complete culture. In other
words, most fungal hyphae that were exposed to both chitinases
and caspofungin were disrupted. The cells unexposed to
caspofungin look very regular with a normal cell wall, with
Calcofluor staining mainly seen in regularly spaced septa, whereas
Figure 3. In vitro binding of recombinant chitinases to A. fumigatus hyphae. Binding of recombinant chitotriosidase (A, B). Binding of
recombinant chitotriosidase when incubated in combination with recombinant AMCase (C, D) and binding of recombinant AMCase (E, F). Panels A, C
and E show unexposed hyphae. Panels B, D and F show caspofungin-exposed hyphae. A, B: Contrast and brightening were slightly modified in
Photoshop due to the lack of colour. C, D, E, F: Photos were not modified in Photoshop. A–B Original magnification6100. C–F Original magnification
6400. Slides were stained according to the described protocols. Binding of either recombinant enzyme is characterized by a red colour. Recombinant
chitotriosidase did not bind to unexposed hyphae (A) or to caspofungin-exposed hyphae (B). When incubated with a combination of recombinant
chitotriosidase and recombinant AMCase, recombinant chitotriosidase did bind to unexposed hyphae (arrow) and to conidial heads (C) and seemed
to be taken up by the fungal cells after caspofungin exposure (D). Also the cell wall seemed to be lysed at several locations (arrows). Recombinant
AMCase did bind to unexposed (E) and to caspofungin-exposed hyphae (F).
doi:10.1371/journal.pone.0075848.g003
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the caspofungin-exposed cells show an irregular cell wall with a
fragmented aspect. When fungal cells were incubated with a single
recombinant chitinase, the cell wall remained regular. When
fungal cells were exposed to caspofungin only, the cell wall looked
very regular and similar to that in Figure 4A. Thus, in this assay,
we confirmed the earlier observations of disruption of the fungal
cell wall after exposure to caspofungin and both chitinases. The
observed damage to the fungal cell wall makes it very unlikely that
the fungal cells remain viable.
Discussion
The role of mammalian chitinases in the response of invasive
fungal infections is a relatively unexplored area of research. In the
past it has been shown that chitinase activity was increased in
guinea pigs upon A. fumigatus systemic infection, but it was not
known which chitinase was involved [18,19]. In the present study
we confirmed that chitinases in the lung of immunocompetent rats
and of immunocompromised rats were increased after exposure to
A. fumigatus conidia. We demonstrated that both chitotriosidase
and AMCase play a role. We showed that in immunocompetent
rats with an appropriate immune system, transient exposure to a
high load of conidia without subsequent lung infection resulted in
only a moderate increase in the production and activity of
chitinases in the lung. Based on our findings, we expect that in
certain groups of immunocompetent A. fumigatus-colonized pa-
tients (such as cystic fibrosis patients), chitinase activity levels
would be slightly increased on a permanent basis. We studied
chitinase activity in rats with IPA, though extrapolation to the
human situation should be done with care.
In all immunocompromised rats developing IPA after inhalation
of conidia, chitinases were produced, even though the rats were in
neutropenic state. Since A. fumigatus itself also produces chitinases,
we had to determine if the chitinases measured with our assays
were of host origin. We therefore included in vitro controls for both
the enzyme-assays and immunohistochemistry experiments. These
controls were prepared by growing A. fumigatus in vitro, without
animal cells. No enzyme-activity was observed with the substrates
used and no binding of the AMCase and chitotriosidase was
observed. Since in vitro simulations are not completely represen-
tative for the in vivo situation, it is not easy to rule out that the
fungal chitinases, which might be induced in vivo only, were not
cross-reacting in our assays. The assays used in our study were
similar to the assays used by Overdijk et al [18,19]. He
demonstrated with a Bio-Gel P-100 gel filtration assay that the
chitinase activity in the lung consisted of two peaks, one of 35 kDa
and one of 15 kDa, which both appeared to be true chitinases
[19]. To rule out a fungal origin of the chitinase activity measured
in the lungs of A. fumigatus infected guinea pigs, Overdijk et al
demonstrated that the A. fumigatus chitinases eluted much earlier
from the column than the mammalian chitinases [19]. Further-
more, allosamidin reduced the chitinase activity in infected and in
uninfected guinea pigs by 94% [18]. His final proof was that the
activity ratio with the substrates 4-methylumbelliferyl-N-acetylglu-
cosamine and 4-methylumbelliferyl-N-acetylgalactosamine dif-
fered significantly between A. fumigatus chitinases and chitinases
present in guinea pig serum [18].
It is known that chitotriosidase and AMCase are produced by
several cells, such as alveolar macrophages, epithelial cells and
neutrophils [11,22,23]. Our observations show that chitinase
activity was increased significantly during A. fumigatus infection,
even in rats with decreased numbers of neutrophils and
macrophages. During progression to IPA, both the amount of
fungal material and the chitinase activity increased in the lung
over time.
Treatment with antifungal agents reduces the fungal mass
present in the lung. Therefore it was not surprising that Overdijk et
al. found that treatment of systemic aspergillosis with itraconazole
or amphotericin B limited the increase in chitinase activity in
guinea pigs [18]. Caspofungin belongs to another class of
antifungal agents. It restricts the growth of A. fumigatus in the lung
and it alters the cell wall composition by decreasing the amount of
b-glucan and increasing the amount of chitin in the fungal cell wall
[6]. Since caspofungin both reduces the fungal mass in the lung
Figure 4. Calcofluor White staining of in vitro cultured A. fumigatus hyphae after incubation with recombinant chitotriosidase and
recombinant AMCase. When hyphae were cultured on Sabauroud’s agar (A), the cell wall remained regular and intact after incubation with the
two recombinant chitinases. When hyphae were cultured on Sabauroud’s agar with 1 mg/L caspofungin (B), the cell wall was irregular and disrupted
after incubation with the two recombinant chitinases.
doi:10.1371/journal.pone.0075848.g004
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but also increases the relative chitin concentration within this
mass, resulting in more substrate for the chitinases, the chitinase
activity could either be decreased or increased upon treatment.
In our study we found a trend towards a blunting of the
chitinase response following treatment with caspofungin, sug-
gesting that the total amount of fungal cells seems to be more
important than the composition of the cell wall in the induction
of chitinase expression. The total chitinase activity was lower in
lungs of caspofungin treated rats than in untreated rats. In
contrast, expression of both chitinases seemed to be higher
around the fungal focus in caspofungin treated rats. This could
be explained by the methods used. Chitinase activity was
measured in homogenate of a complete lung, whereas the
immunohistochemistry shown displays only the fungal focus.
Thus the images shown are not representative for the complete
lung, since the fungal focus is located in only a limited segment
of the lung. Furthermore it became clear again that caspofungin
does not have fungicidal or fungistatic activity. This was
supported by the high GM-index of infected, caspofungin-
treated rats (Figure 1A). The high GM-index on day 3 could be
explained by the detachment of the galactomannan chain from
the b-glucan polymeres, caused by caspofungin treatment.
Caspofungin is currently in use as salvage therapy for fungal
infections. Future studies will be performed to determine if the
chitinases also work synergistic with other antifungal agents such
as the azoles and polyenes.
Although total chitinase activity in infected rats was not
influenced by treatment with caspofungin, the location of the
individual chitinases was substantially changed. Upon caspofungin
treatment, both AMCase and chitotriosidase seemed to bind to the
fungal hyphae, which was not found in untreated infected rats.
Furthermore, galactomannan is released from the cell wall
resulting in the unmasking of b-glucan and chitin on the A.
fumigatus cell wall. Unmasking b-glucan has been shown to result in
an increased inflammatory response compared to untreated
hyphae [24]. The unmasking of the chitin polymers, the target
of the chitinases, seems to cause enhanced binding of chitinases to
chitin. Possibly, treatment with caspofungin increased the avail-
able mammalian chitinase binding domains in the fungus, which
might be responsible for the good clinical outcome of treatment
with this agent.
It appeared that AMCase was located on the fungal cell wall,
while chitotriosidase was located inside the fungal cells. The
observed expression patterns suggest that AMCase and chitotrio-
sidase each have a distinct target location and bind to different
parts of the fungal cell. It was shown that recombinant AMCase in
vitro indeed bound the hyphae but that recombinant chitotriosidase
was taken up by hyphae only after exposure to both chitinases,
thus mimicking the in vivo situation where also both chitinases are
present. It seemed that recombinant chitotriosidase needed the
exochitinase activity of recombinant AMCase in order to be taken
up by the fungus. This suggests a synergy between endochitinases
and exochitinases. Bolar et al also suggested that endochitinases
and exochitinases act synergistically in plants [25]. They showed
that plants expressing both types of chitinases were less susceptible
to Venturia inaequalis, the fungal causal agent of apple scab, than
plants expressing one of the chitinases [25]. Our observations
suggest that such a type of synergy may also be present in
mammals.
The synergy between chitotriosidase and AMCase seemed most
important when A. fumigatus was exposed to caspofungin in vitro.
When A. fumigatus was incubated with caspofungin and both
chitotriosidase and AMCase, a direct cell wall degrading effect was
noted. No degradation was found when only one of the chitinases
was used or when the fungus was not exposed to caspofungin.
Also, when the in vitro susceptibility assays were performed with
each chitinase alone, or when combined with caspofungin, no
direct fungicidal effect was observed. Several other authors also
investigated activity of chitotriosidase and AMCase, with varying
results [11,26]. Differences in experimental setup could explain the
differences found in antifungal activity.
The cell wall degrading properties of both chitinases in
combination with exposure to caspofungin could explain why
treatment with caspofungin results in decreased mortality in
IPA, in spite of the limited fungicidal properties in vitro.
However, chitotriosidase and AMCase are not expected to be
the only type of host response that will be changed upon
caspofungin treatment. Since caspofungin alters the composi-
tion of the fungal cell wall, it will also alter the pathogen
associated molecular patterns (PAMPs) exposed on fungal cells.
This alteration in PAMPs could result in a changed
production and expression of other signalling molecules, e.g.
cytokines and chemokines, contributing to the process of
fungal killing. It is expected that killing of fungal cells is
achieved by caspofungin treatment in combination with the
immune system by using direct and indirect signalling
molecules including chitinases. However, the combined action
of signalling molecules and mediators with chitinases needs to
be elucidated in the future.
Supporting Information
Table S1 Enzyme activities of chitotriosidase and AM-
Case (in a.u.) in rats in several conditions, prior to
inoculation and on day 1, day 3 and day 6 after
inoculation. The conditions represented are immunocompetent
rats, immunocompromised rats receiving no treatment at all,
immunocompromised rats receiving caspofungin treatment from
24 h after infection and immunocompromised rats receiving
caspofungin treatment from 72 h after infection.
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